Iconovo AB (publ) (ICO.ST)
SEK 4.17
(-2.11%)
SEK 4.17
(-2.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 128.07 Million SEK | 5.62% |
| 2022 | 121.26 Million SEK | -18.36% |
| 2021 | 148.54 Million SEK | 47.01% |
| 2020 | 101.04 Million SEK | -11.17% |
| 2019 | 113.75 Million SEK | 56.47% |
| 2018 | 72.7 Million SEK | 72.7% |
| 2017 | 42.09 Million SEK | 109.37% |
| 2016 | 20.1 Million SEK | 75.35% |
| 2015 | 11.46 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 129.02 Million SEK | -9.93% |
| 2024 Q1 | 153.61 Million SEK | 19.94% |
| 2024 Q2 | 143.25 Million SEK | -6.74% |
| 2023 FY | 128.07 Million SEK | 5.62% |
| 2023 Q3 | 142.58 Million SEK | 3.36% |
| 2023 Q2 | 137.94 Million SEK | -9.28% |
| 2023 Q4 | 128.07 Million SEK | -10.17% |
| 2023 Q1 | 152.06 Million SEK | 25.4% |
| 2022 Q2 | 143.74 Million SEK | -6.72% |
| 2022 Q4 | 121.26 Million SEK | -14.16% |
| 2022 FY | 121.26 Million SEK | -18.36% |
| 2022 Q1 | 154.09 Million SEK | 3.74% |
| 2022 Q3 | 141.26 Million SEK | -1.72% |
| 2021 Q1 | 93.55 Million SEK | -7.42% |
| 2021 FY | 148.54 Million SEK | 47.01% |
| 2021 Q4 | 148.54 Million SEK | -3.77% |
| 2021 Q3 | 154.35 Million SEK | 74.17% |
| 2021 Q2 | 88.62 Million SEK | -5.27% |
| 2020 Q4 | 101.04 Million SEK | -3.11% |
| 2020 FY | 101.04 Million SEK | -11.17% |
| 2020 Q1 | 111.24 Million SEK | -2.21% |
| 2020 Q2 | 106.58 Million SEK | -4.19% |
| 2020 Q3 | 104.29 Million SEK | -2.15% |
| 2019 Q1 | 68.45 Million SEK | -5.84% |
| 2019 Q4 | 113.75 Million SEK | 76.68% |
| 2019 Q3 | 64.38 Million SEK | -2.59% |
| 2019 FY | 113.75 Million SEK | 56.47% |
| 2019 Q2 | 66.09 Million SEK | -3.45% |
| 2018 Q3 | 71.21 Million SEK | -3.23% |
| 2018 FY | 72.7 Million SEK | 72.7% |
| 2018 Q1 | 73.65 Million SEK | 74.96% |
| 2018 Q2 | 73.59 Million SEK | -0.09% |
| 2018 Q4 | 72.7 Million SEK | 2.09% |
| 2017 FY | 42.09 Million SEK | 109.37% |
| 2017 Q4 | 42.09 Million SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 FY | 20.1 Million SEK | 75.35% |
| 2015 FY | 11.46 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -103.676% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 96.104% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 96.104% |
| Arcoma AB | 81.96 Million SEK | -56.267% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | 81.244% |
| BICO Group AB (publ) | 10.19 Billion SEK | 98.744% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | 83.038% |
| CellaVision AB (publ) | 928.71 Million SEK | 86.209% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -121.879% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -483.362% |
| C-Rad AB (publ) | 404 Million SEK | 68.297% |
| Duearity AB (publ) | 15.14 Million SEK | -745.747% |
| Dignitana AB (publ) | 44.83 Million SEK | -185.695% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -22.8% |
| Getinge AB (publ) | 55.09 Billion SEK | 99.768% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -24.788% |
| Integrum AB (publ) | 164.85 Million SEK | 22.309% |
| Luxbright AB (publ) | 40.68 Million SEK | -214.796% |
| Mentice AB (publ) | 322.52 Million SEK | 60.289% |
| OssDsign AB (publ) | 356.38 Million SEK | 64.062% |
| Paxman AB (publ) | 167.12 Million SEK | 23.363% |
| Promimic AB (publ) | 92.87 Million SEK | -37.906% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -228.023% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -99.086% |
| ScandiDos AB (publ) | 81.47 Million SEK | -57.205% |
| Sectra AB (publ) | 3.21 Billion SEK | 96.011% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 87.37% |
| Senzime AB (publ) | 433.54 Million SEK | 70.457% |
| SpectraCure AB (publ) | 144.83 Million SEK | 11.568% |
| Stille AB | 804.89 Million SEK | 84.087% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 99.219% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 94.167% |